$4.01
-0.43-9.68%
Last update: Nov 5, 5:37 PM
Gyre Therapeutics Inc
GYRENASDAQ
The average analyst price target for Gyre Therapeutics is $17, 325.0% above the current price. Of 2 analysts, 2 rate it Buy. Targets range from $16 to $18. The latest change came on Oct 10, 2025, when Jefferies initiated coverage of Gyre Therapeutics with a Buy rating and a $16 price target.
Price Target Range — 2 Quarters
Analyst Consensus — 2 Analysts
Rating Trend — Last 9 Months
